Non-inflammatory cerebral amyloid angiopathy as a cause of rapidly progressive dementia: A case study

Area of Science:

• Neurology
• Neuroscience
• Pathology

Background:

• Cerebral amyloid angiopathy (CAA) is a significant cause of cognitive impairment and intracerebral hemorrhage, particularly in the elderly.
• Understanding the pathological mechanisms of CAA is crucial for developing effective treatments for dementia and related neurological disorders.

Observation:

• A 77-year-old male presented with subacute, rapidly progressive cognitive decline, hemiparesis, and hemineglect.
• Brain MRI revealed microhemorrhages and white matter hyperintensities, indicative of cerebrovascular damage.
• Brain biopsy confirmed amyloid-beta peptide deposition in vessel walls, associated with microbleeds.

Findings:

• The patient's rapid cognitive decline and neurological deficits were attributed to cerebral amyloid angiopathy.
• Pathological findings included amyloid deposition, microhemorrhages, and white matter lesions, suggesting vascular damage and potential co-morbidity with Alzheimer's disease.
• The case underscores the role of CAA-related inflammation as a recently described factor in cognitive impairment.

Implications:

• This case emphasizes the importance of considering CAA in the differential diagnosis of rapidly progressive cognitive decline.
• Early recognition and management of CAA may help mitigate severe neurological outcomes.
• Further research into CAA pathogenesis, including inflammatory aspects, is warranted to improve patient outcomes.